Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization

José F. Varona, Pedro Landete, View ORCID ProfileJose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortún, Roberto Vates, José Barberán, Bonaventura Clotet, Julio Ancochea, Daniel Carnevali, Noemí Cabello, Lourdes Porras, Paloma Gijón, Alfonso Monereo, Daniel Abad, Sonia Zúñiga, Isabel Sola, Jordi Rodon, Nuria Izquierdo-Useros, Salvador Fudio, María José Pontes, Beatriz de Rivas, Patricia Girón de Velasco, Belén Sopesén, Antonio Nieto, Javier Gómez, Pablo Avilés, Rubin Lubomirov, Kris M. White, Romel Rosales, Soner Yildiz, Ann-Kathrin Reuschl, Lucy G. Thorne, Clare Jolly, Greg J. Towers, Lorena Zuliani-Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Luis Enjuanes, Jose M. Fernández-Sousa, Plitidepsin – COVID - 19 Study Group, Nevan J. Krogan, José M. Jimeno, Adolfo García-Sastre
doi: https://doi.org/10.1101/2021.05.25.21257505
José F. Varona
1Departamento de Medicina Interna, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain
2Facultad de Medicina, Universidad San Pablo-CEU, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jfvarona@hmhospitales.com Adolfo.Garcia-Sastre@mssm.edu Nevan.Krogan@ucsf.edu
Pedro Landete
3Hospital Universitario La Princesa, Madrid, Spain
4Universidad Autónoma de Madrid, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose A. Lopez-Martin
5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jose A. Lopez-Martin
Vicente Estrada
6Hospital Clínico San Carlos, Madrid, Spain
7Universidad Complutense de Madrid, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Paredes
8Infectious Diseases Department, irsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
9Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Guisado-Vasco
10Internal Medicine Department. Hospital Universitario Quironsalud Madrid, Madrid, Spain
11Universidad Europea, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucía Fernández de Orueta
11Universidad Europea, Madrid, Spain
12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Torralba
13Health Sciences Faculty, University of Alcalá, Madrid, Spain
14Guadalajara University Hospital, Guadalajara, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesús Fortún
15Hospital Universitario Ramón y Cajal, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Vates
12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Barberán
1Departamento de Medicina Interna, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain
2Facultad de Medicina, Universidad San Pablo-CEU, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bonaventura Clotet
8Infectious Diseases Department, irsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
9Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain
16Universitat Autònoma de Barcelona, Barcelona, Spain
17Universitat de Vic, Universitat Central de Catalunya Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio Ancochea
3Hospital Universitario La Princesa, Madrid, Spain
4Universidad Autónoma de Madrid, Madrid, Spain
18Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Carnevali
10Internal Medicine Department. Hospital Universitario Quironsalud Madrid, Madrid, Spain
11Universidad Europea, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noemí Cabello
19Infectious Diseases Department, Clinico San Carlos University Hospital, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lourdes Porras
20Internal Medicine, Hospital General de Ciudad Real, Ciudad Real, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paloma Gijón
21Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfonso Monereo
12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Abad
11Universidad Europea, Madrid, Spain
12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia Zúñiga
22Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Sola
22Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordi Rodon
23IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la UAB, Bellaterra, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nuria Izquierdo-Useros
24IrsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
25Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelone, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salvador Fudio
26Clinical Pharmacology Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María José Pontes
27Medical Affairs, PharmaMar, Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatriz de Rivas
27Medical Affairs, PharmaMar, Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Girón de Velasco
5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belén Sopesén
5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
28Sylentis, S.A.U., Tres Cantos, Madrid, Spain
29Biocross, S.L., Valladolid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Nieto
30Bio Statistics Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Gómez
30Bio Statistics Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Avilés
31Preclinical Unit, Pharmamar, Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rubin Lubomirov
26Clinical Pharmacology Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kris M. White
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Romel Rosales
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soner Yildiz
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann-Kathrin Reuschl
34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucy G. Thorne
34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Jolly
34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg J. Towers
34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorena Zuliani-Alvarez
35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
36J. David Gladstone Institutes, San Francisco, CA 94158, USA
37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehdi Bouhaddou
35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
36J. David Gladstone Institutes, San Francisco, CA 94158, USA
37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten Obernier
35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
36J. David Gladstone Institutes, San Francisco, CA 94158, USA
37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Enjuanes
22Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose M. Fernández-Sousa
39Pharmamar, Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nevan J. Krogan
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
36J. David Gladstone Institutes, San Francisco, CA 94158, USA
37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jfvarona@hmhospitales.com Adolfo.Garcia-Sastre@mssm.edu Nevan.Krogan@ucsf.edu
José M. Jimeno
5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adolfo García-Sastre
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
40Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA
41Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jfvarona@hmhospitales.com Adolfo.Garcia-Sastre@mssm.edu Nevan.Krogan@ucsf.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Plitidepsin is a marine-derived cyclic-peptide that inhibits SARS-CoV-2 replication at low nanomolar concentrations by the targeting of host protein eEF1A (eukaryotic translation-elongation-factor-1A). We evaluated a model of intervention with plitidepsin in hospitalized COVID-19 adult patients where three doses were assessed (1.5, 2 and 2.5 mg/day for 3 days, as a 90-minute intravenous infusion) in 45 patients (15 per dose-cohort). Treatment was well tolerated, with only two Grade 3 treatment-related adverse events observed (hypersensitivity and diarrhea). The discharge rates by Days 8 and 15 were 56.8% and 81.8%, respectively, with data sustaining dose-effect. A mean 4.2 log10 viral load reduction was attained by Day 15. Improvement in inflammation markers was also noted in a seemingly dose-dependent manner. These results suggest that plitidepsin impacts the outcome of patients with COVID-19.

One-Sentence Summary Plitidepsin, an inhibitor of SARS-Cov-2 in vitro, is safe and positively influences the outcome of patients hospitalized with COVID-19.

Competing Interest Statement

Vicente Estrada has received personal fees from Janssen, Gilead, and ViiV and grants from MSD. Roger Paredes has participated in Advisory Boards from Gilead, MSD, ViiV Healthcare and Theratechnologies. Miguel Torralba has received consulting fees as a member of Advisory Committee and honoraria and speaking fees from Gilead, Janssen, MSD and ViiV Companies. Jesus Fortun has participated in scientific events and received consulting or speaking fees or oral presentations from: Pfizer, Gilead, MSD, Astellas, Novartis and Roche. Julio Ancoechea has received fees for scientific consulting and/or speaking from Actelion, Air Liquide, Almirall, AstraZeneca, Boehringer Ingelheim, Carburos Medica, Chiesi, Faes Farma, Ferrer, GlaxoSmithKline, InterMune, Linde Healthcare, Menarini, MSD, Mundipharma, Novartis, Pfizer, Roche, Rovi, Sandoz, Takeda and Teva. Isabel Sola, Sonia Zuniga and Luis Enjuanes hold a Technology Support contract with Pharmamar. Nuria Izquierdo-Useros is inventor of a patent of Plitidepsin (EP20382821.5). The Krogan Laboratory has received research support from Vir Biotechnology and F. Hoffmann-La Roche. Nevan Krogan has consulting agreements with Maze Therapeutics and Interline Therapeutics, and is a shareholder of Tenaya Therapeutics. Jose M. Fernandez-Sousa is President and Founder of Pharmamar, S.A. (Madrid, Spain). Jose Jimeno holds stocks of Pangaea Oncology, has a non-remunerated role in the Scientific Advisory Board and holds stocks of Phosplatin Therapeutics; and is a full-time employee of PharmaMar, S.A. (Madrid, Spain).The A.G.-S. laboratory has received research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, PharmaMar, ImmunityBio, Accurius and Nanocomposix. Adolfo Garcia-Sastre has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak and Pfizer. A.G.-S. is inventor on patents and patent application on the use of antivirals for the treatment of virus infections, owned by the Icahn School of Medicine at Mount Sinai, New York. A patent application based on this work has been filed (EP20382821.5). Jose A. Lopez-Martin, Salvador Fudio, Maria Jose Pontes, Beatriz de Rivas, Belen Sopesen, Antonio Nieto, Javier Gomez, Patricia Giron de Velasco, Pablo Aviles and Rubin Lubomirov are employees and shareholders of PharmaMar, S.A (Madrid, Spain). Jose A. Lopez-Martin is a co-inventor of a patent for plitidepsin (WO2008135793A1). Jose M. Jimeno is a co-inventor on a patent for didemnin (WO99/42125) and on patents for aplidine (WO03/033013 and WO 2004/080421).

Clinical Trial

EudraCT #2020-001993-31 NCT #04382066

Funding Statement

This study has been funded by Pharmamar, S.A. (Madrid, Spain). This work was supported by grants from the Government of Spain (PIE_INTRAMURAL_ LINEA 1 - 202020E079; PIE_INTRAMURAL_CSIC-202020E043). The research of CBIG consortium (constituted by IRTA-CReSA, BSC, & IrsiCaixa) is supported by Grifols pharmaceutical. We also acknowledge the crowdfunding initiative #Yomecorono (https://www.yomecorono.com). N.I.U. has non-restrictive funding from PharmaMar to study the antiviral effect of Plitidepsin. N.J.K. was funded by grants from the National Institutes of Health (P50AI150476, U19AI135990, U19AI135972, R01AI143292, R01AI120694, and P01AI063302); by the Excellence in Research Award (ERA) from the Laboratory for Genomics Research (LGR), a collaboration between UCSF, UCB, and GSK (#133122P); by the Roddenberry Foundation, and gifts from QCRG philanthropic donors. This work was supported by the Defense Advanced Research Projects Agency (DARPA) under Cooperative Agreement #HR0011-19-2-0020. The views, opinions, and/or findings contained in this material are those of the authors and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government. This research was partly funded by CRIP (Center for Research for Influenza Pathogenesis), a NIAID supported Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C), by DARPA grant HR0011-19-2-0020, by supplements to NIAID grants U19AI142733, U19AI135972 and DoD grant W81XWH-20-1-0270, and by the generous support of the JPB Foundation, the Open Philanthropy Project (research grant 2020-215611 (5384)), and anonymous donors to AG-S. S.Y. received funding from a Swiss National Foundation (SNF) Early Postdoc Mobility fellowship (P2GEP3_184202).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

HM Hospitals Drug Research Ethics Committee (CEIm HM Hospitales) 28660 - Boadilla del Monte (Madrid, Spain)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵‡ A full list of the authors and affiliations included in the Supplementary Materials.

Data Availability

Plitidepsin is available from PharmaMar for noncommercial use under an MTA. All relevant data are included within this manuscript and all materials other than plitidepsin are readily available upon request from the corresponding authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F. Varona, Pedro Landete, Jose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortún, Roberto Vates, José Barberán, Bonaventura Clotet, Julio Ancochea, Daniel Carnevali, Noemí Cabello, Lourdes Porras, Paloma Gijón, Alfonso Monereo, Daniel Abad, Sonia Zúñiga, Isabel Sola, Jordi Rodon, Nuria Izquierdo-Useros, Salvador Fudio, María José Pontes, Beatriz de Rivas, Patricia Girón de Velasco, Belén Sopesén, Antonio Nieto, Javier Gómez, Pablo Avilés, Rubin Lubomirov, Kris M. White, Romel Rosales, Soner Yildiz, Ann-Kathrin Reuschl, Lucy G. Thorne, Clare Jolly, Greg J. Towers, Lorena Zuliani-Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Luis Enjuanes, Jose M. Fernández-Sousa, Plitidepsin – COVID - 19 Study Group, Nevan J. Krogan, José M. Jimeno, Adolfo García-Sastre
medRxiv 2021.05.25.21257505; doi: https://doi.org/10.1101/2021.05.25.21257505
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F. Varona, Pedro Landete, Jose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortún, Roberto Vates, José Barberán, Bonaventura Clotet, Julio Ancochea, Daniel Carnevali, Noemí Cabello, Lourdes Porras, Paloma Gijón, Alfonso Monereo, Daniel Abad, Sonia Zúñiga, Isabel Sola, Jordi Rodon, Nuria Izquierdo-Useros, Salvador Fudio, María José Pontes, Beatriz de Rivas, Patricia Girón de Velasco, Belén Sopesén, Antonio Nieto, Javier Gómez, Pablo Avilés, Rubin Lubomirov, Kris M. White, Romel Rosales, Soner Yildiz, Ann-Kathrin Reuschl, Lucy G. Thorne, Clare Jolly, Greg J. Towers, Lorena Zuliani-Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Luis Enjuanes, Jose M. Fernández-Sousa, Plitidepsin – COVID - 19 Study Group, Nevan J. Krogan, José M. Jimeno, Adolfo García-Sastre
medRxiv 2021.05.25.21257505; doi: https://doi.org/10.1101/2021.05.25.21257505

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (553)
  • Anesthesia (135)
  • Cardiovascular Medicine (1761)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (660)
  • Epidemiology (10803)
  • Forensic Medicine (8)
  • Gastroenterology (592)
  • Genetic and Genomic Medicine (2952)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1930)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (631)
  • Infectious Diseases (except HIV/AIDS) (12519)
  • Intensive Care and Critical Care Medicine (693)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2801)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1469)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (867)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (337)
  • Psychiatry and Clinical Psychology (2641)
  • Public and Global Health (5374)
  • Radiology and Imaging (1013)
  • Rehabilitation Medicine and Physical Therapy (596)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (125)